# New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor's Address
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2014-07-02 · Effective 2014-07-02 · 79 FR 37617
## Document
- **Document number:** 2014-15276
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 79 FR 37617
- **CFR reference:** 21 CFR 510
- **Publication date:** 2014-07-02
- **Effective date:** 2014-07-02
- **HHS docket:** Docket No. FDA-2014-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during April and May 2014. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to remove an obsolete entry for a drug for which approval was withdrawn in 1996.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2014/07/02/2014-15276/new-animal-drugs-afoxalaner-ceftiofur-crystalline-free-acid-chloramine-t-clodronate-enrofloxacin)
---
*AI Analytics · CC0 1.0*